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ABSTRACT
We describe a Multiplex Primer Prediction (MPP)
algorithm to build multiplex compatible primer
sets to amplify all members of large, diverse and
unalignable sets of target sequences. The MPP
algorithm is scalable to larger target sets than
other available software, and it does not require a
multiple sequence alignment. We applied it to
questions in viral detection, and demonstrated
that there are no universally conserved priming
sequences among viruses and that it could require
an unfeasibly large number of primers ( 3700
18-mers or  2000 10-mers) to generate amplicons
from all sequenced viruses. We then designed
primer sets separately for each viral family, and for
several diverse species such as foot-and-mouth
disease virus (FMDV), hemagglutinin (HA) and
neuraminidase (NA) segments of influenza A virus,
Norwalk virus, and HIV-1. We empirically demon-
strated the application of the software with a
multiplex set of 16 short (10nt) primers designed
to amplify the Poxviridae family to produce a
specific amplicon from vaccinia virus.
INTRODUCTION
Researchers employ numerous approaches for viral detec-
tion and discovery, including metagenomic sequencing
(1–3), microarrays (4–9) or multiplex PCR followed
by other methods of characterization such as mass
spectrometry (10–14), suspension arrays (15,16) or
amplicon sequencing (17). Multiplex PCR followed by
analysis of ampliﬁed products ﬁlls a niche for viral iden-
tiﬁcation when singleplex PCR has failed or there are
a few dozen likely candidates but the expense of
metagenomic sequencing or high-density microarrays is
unwarranted (18). However, multiplex primer design for
many highly divergent targets is challenging since no uni-
versally conserved primers may exist, and ﬁnding sets of
primers likely to function well in multiplex (e.g. isothermal
Tm’s, no primer dimers) adds to the complexity of ﬁnding
conserved primer candidates. Primer design software that
requires a multiple sequence alignment (MSA) as input
can be problematic for diverse target sets, as MSAs can
be diﬃcult to construct, exhausting memory or available
time before an alignment is completed. Even if an align-
ment does complete for divergent target sets such as all
members of a family of RNA viruses or gene homologues
across species, alignments may show little nucleotide
sequence conservation, and multiple primers are required
to amplify all targets. Considering the challenges of primer
design for targets showing sequence variation, it is not
surprising that many of the PCR-based assays in the
literature are predicted to fail to detect desired targets
when compared against available sequence data, and
this problem is worst at higher taxonomic levels like
family (19).
Most currently available multiplex primer prediction
tools require an MSA (20–24). None of those tools build
multiplex sets in which no primers in the set are predicted
to form primer-dimers, although some avoid homodimers.
We attempted to run a number of alternative software
tools for multiplex or degenerate primer prediction
for several species level target sets ranging in size from
41 to  6000 sequences: Primaclade (24), FastPCR (www
.biocenter.helsinki.ﬁ/bi/programs/fastpcr.htm), GeneUp
(25), PDA-MS/UniQ software (26), Greene SCPrimer
(20) and HYDEN (22). Only Greene SCPrimer and
HYDEN could handle the two smallest, species-level
target sets (Norwalk virus and FMDV), and none of the
tools completed for the larger target sets that we
attempted to run.
Therefore, we designed the MPP software to avoid the
requirement of an MSA and to scale better for large and
diverse target sets. MPP builds a multiplex-compatible set
of primers capable of amplifying all target sequences,
attempting to minimize the number primers in the set.
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sal’ primers for viruses, akin to the highly conserved 16S
rRNA universal primers for bacteria. Throughout, we use
the term ‘detected’ to mean that there should be at least
one PCR product. This is a loose deﬁnition of ‘detected’
adopted for convenience in the following discussions, and
we recognize that a PCR product may prove insuﬃcient
for viral characterization. We predicted a set of ‘universal
viral primers’ for all available complete genomes of
all viruses, and found that the number of universal viral
primers would be impractical to implement, even if short,
highly conserved priming sequences were used. Then
we predicted family-level primer sets for every viral
family, as well as for several highly diverse species of
RNA viruses, for primers of a traditional length as well
as nontraditional, shorter, more highly conserved primers,
which are more likely to amplify novel, unsequenced
viruses and which could be an alternative to degenerate
primers. While the software uses a greedy algorithm that
may settle at a local minimum which is above the true
minimal set, it generated primer sets for each viral
family with fewer than half the number of primers that
would be expected without optimization. Although
family-level primer sets for some families are too large
to be practical, 64% of the families had primer sets
of no more than 20 primer pairs, quite feasible for
multiplex PCR.
Finally, we empirically multiplexed a set of 16 short
(10-mer) primers designed for the Poxviridae family.
This demonstrated speciﬁc ampliﬁcation of the expected
viral fragment from vaccinia Lister strain. This prelimi-
nary demonstration suggests that speciﬁc ampliﬁcation
with family-level multiplexed sets of short primers might
be feasible for viral detection and discovery, particularly
as a means for selective enrichment of viral target for
downstream amplicon characterization (e.g. sequencing
or probe hybridization).
METHODS
MPP algorithm for calculating multiplexed primer sets
Here, we outline a greedy algorithm used to calculate con-
served sets of multiplexed primers to amplify fragments
from each member of a target set of sequences, and
provide a more detailed description in the Supplementary
Methods. First, we enumerate all candidate oligos ﬁtting
user-speciﬁed requirements for length, Tm, and lack of
hairpin formation. We rank pairs of these by the
number of targets in which that pair occurs within a
distance range d1 bases to d2 bases of one another,
where these might be speciﬁed so as to bound a reasonable
range for a downstream characterization method such
electrophoretic discrimination of bands, probe hybridiza-
tion or sequencing. The most frequent pair is selected as
primers. The process is repeated for the remaining targets
that would not have an amplicon from the ﬁrst pair, with
the added consideration that new primers selected be
predicted not to form dimers with other primers already
selected, as well as can be predicted based on nearest
neighbor thermodynamic predictions (27), although free
energy calculations cannot predict with certainty that
primer dimers will be excluded in practice. There is an
option to bin primers into reaction subsets, if desired.
With binning, primers are added to a bin until that bin
contains b primers, at which point a new bin is begun,
following the same process. Binning primers in smaller
groups avoids exclusion of the most highly conserved
oligos because of primer dimer free energy constraints.
The universal set of primers is the set of selected primers
to amplify all genomes in the target set. The primers
within a bin should be multiplexed into a single PCR
reaction, but each bin should be run separately. This is a
simple binning strategy, and alternative strategies could be
employed such as starting a new bin with any primer pair
that dimerizes with other previously selected primers
regardless of the number of primers in the bin, but this
could have the possible disadvantage of bin explosion to
numerous singleplex or small multiplex reactions. The
graph-based algorithm of MuPlex (28,29) is another
binning strategy that could be incorporated. Output on
the number of primers rejected due to the various ﬁlters
(Tm, hairpin free energy, etc.) is printed to standard
output after each round of primer pairs are selected and
also cumulatively, so a user can monitor if/which
parameters might be too stringent. If an alternative set
of primers is desired that does not overlap with the set
selected, one can replace with N’s the subsequences
matching the selected primers and their reverse
complements in the target sequences and rerun the
software with the modiﬁed input sequences.
The script ﬁnd_amplicons.pl predicts all the amplicons
that should be generated by a list of (multiplexed) primers
mixed with a set of sequences. This PCR-simulating script
lists amplicon sequences, their length and position, and
the forward+reverse primer combination to yield each
product, as well as a summary ﬁle of the fragment
length distributions enabling a quick assessment of how
well each target sequence can be discriminated based
purely on amplicon length patterns. We used this script
to check whether some viral primer sets are predicted to
generate amplicons from the human genome.
For all Tm and free energy predictions, we used the
following Unafold settings: [Na+]=0.2M, [Mg+]=
0.0015, annealing temperature=30 C, and strand con-
centration of each strand=10
–7M, making the total
strand concentration of both strands=2 10
–7.
Imposing uniqueness requirements for target-speciﬁc
priming
The MPP algorithm described here focuses on ﬁnding
conserved primers, and does not require that the primers
be family- or species-speciﬁc. For the runs predicting
family-speciﬁc primers, we designed viral family primers
that were unique relative to nontarget viral families by
replacing any substring of 17nt or longer that occurs in
any non-target family with a substring of ‘N’’s, using the
suﬃx array software vmatch (http://www.vmatch.de/).
MPP eliminates oligos with N’s from consideration as
primers. This approach is simple, although it risks being
overly strict by eliminating some potentially successful
6292 Nucleic Acids Research, 2009,Vol.37, No. 19candidate primers, since it disallows those cases where
a single nonunique primer pairs with a unique primer,
a pair of nonunique primers are too far apart to
actually generate an amplicon in a nontarget sequence,
or candidate oligos partially overlap a nonunique
stretch of N’s.
In general, searching for primers from sequence that
is speciﬁc to one set of targets and excluding candi-
date substrings present in nontarget sequence is a useful
strategy to design signatures for pathogen detection. This
can be done by replacing nonunique or nonspeciﬁc
substrings with N’s in the sequences input to MPP using
software such as vmatch.
Runs predicting universal viral primers
For runs predicting universal viral primers including all
viruses at once in the target set, all viral complete genomes
and segments downloaded from publicly available
sequence databases (Genbank, Baylor, TIGR) as of 25
April 2007 were used. Draft sequences with multiple
contigs were merged into a single sequence entry, with
contigs separated by 1000 N’s, a stretch suﬃciently long
(>d2) so that primer pairs would not be designed to fall on
diﬀerent contigs, although there were very few draft
sequences in contigs where this was necessary. Because
of the large numbers of sequences in two families, only
the MP segment sequences from Orthomyxoviridae
and the L segment from Bunyaviridae were included, as
these are the more conserved segments, reducing the
number of targets by 23017 sequences. The total
number of target sequences for these all virus runs were
11477. We predicted a multiplex set of universal 10-mers
without binning the primers into separate reactions, but it
was necessary to use a very low xdimer and xhomodimer of
 11kcal/mol to be possible to predict multiplexed primers
to amplify every target. For the next calculations, we
subdivided the primers into sub-reactions with 20
primers per reaction bin, to avoid excluding primers that
were predicted to form primer dimers, and raised xdimer
and xhomodimer to –7kcal/mol. Primer sets of length 5–18
were predicted (Figure 1). To assess the eﬀect of removing
Tm constraints, we generated universal primer sets with
length but no Tm requirements, and compared the
primer counts to those with Tm constraints (Figure 2).
Primer sets are available by contacting the authors.
We evaluated how the growth of sequence availability
could aﬀect the size of the universal set of viral primers, as
well as our ability to detect unknown/unsequenced
viruses. We predicted a universal viral primer set for all
viral genomes and segments available as of 1 January
2004, totaling 9965 sequences, for primers of length
7–15nt (Figure 2). It was not necessary to exclude any
Orthomyxoviridae or Bunyaviridae segments, because
these segments were not so deeply sequenced at that
time. We then determined how much of the 2007
sequence data would have been detectable using the
2004 primer sets (Figure 3).
To predict how contamination with human DNA might
aﬀect the ability to detect speciﬁc ampliﬁcation of viruses,
the average number of amplicons for the human genome
was also predicted based on these primer sets with
20 primers per bin (Figure 4). The eﬀect of reducing the
multiplex size to 10 primers per reaction on human
genome ampliﬁcation was calculated by dividing priming
sets in half, with 10 primers per reaction.
Viral family primers
Subdividing viral targets into families, we used an updated
set of sequences, downloaded 5 February 2009. For family-
level primers, we computed primer sets using three
alternative parameter settings (Table 1): (i) 17–21-mer
primers with Tm=55–60 C, primers not checked for
uniqueness; (ii) same length and Tm speciﬁcations as in
(i) but eliminating from consideration as primers any
oligos of at least 17nt that occur in nontarget viral
families, as described earlier; and (iii) 10–15-mer primers
with Tm=40–45 C. These primers are available as
Supplementary Data.
Species level primers for several divergent species
We also generated primer sets for several species with high
sequence diversity: HIV-1, FMDV, Norwalk virus and
inﬂuenza A segments HA and NA (summary in Tables 2
and 3, primer sequences available as Supplementary
Data). MPP parameters were the same as in Table S1,
with Tm=35–50 C for 10-mer primers and Tm=55–
70 C for 17–18-mer primers, and sequences were
downloaded in 2007 or 2008 (inﬂuenza only). To illustrate
the challenges of designing primers from an alignment, we
aligned these organisms using MUSCLE (30) when
possible. For the HIV-1 and inﬂuenza A segments HA
and NA, MUSCLE ran out of memory before completing.
An alternative alignment tool, ClustalW (31), had
completed only a small fraction of the alignment after
running for days. Therefore, for these large data sets, a
random selection of  35 sequences for each target was
aligned with MUSCLE, and this alignment was used
to build a proﬁle Hidden Markov Model (HMM)
(hmmbuild) using HMMer (http://hmmer.wustl.edu/).
(32) The full sequence set was then aligned to the
HMM using hmmalign. For Norwalk virus and FMDV,
we designed multiplex-degenerate primer sets using
GreeneSCPrimer (20) and HYDEN (22), but the other
three targets sets were too large for those programs.
None of the other primer prediction programs we tried
(as indicated in the ‘Results’ section) would scale to
handle even these two smallest target sets.
Empirical testing of Poxviridae multiplex primers
For an empirical demonstration of our algorithm, we
tested a multiplex set of 16 short, 10-nt primers designed
for the Poxviridae viral family against commercially
puriﬁed vaccinia virus extracts. The primer sequences are
provided in Table 4 along with the predicted single
amplicon for vaccinia Lister strain. We chose the
Poxviridae family multiplex for these ﬁrst empirical
demonstrations because extracted viral nucleic acid
was readily available for experiments. All primers were
purchased from Integrated DNA Technologies
(Coralville, IA, USA) and resuspended to 100mM stock
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USA). Working solutions containing equimolar concen-
trations of each of the 16 primers were used in all
experiments. Puriﬁed, quantitated vaccinia Lister strain
DNA was purchased at a concentration of 1.3 10
4
copies/ml in nuclease-free water from Advanced
Biotechnologies, Inc. (Columbia, MD, USA). All PCR
experiments were prepared using the Superscript III RT-
PCR kit from Invitrogen (Carlsbad, CA, USA). We
selected the RT-PCR kit in order to establish a protocol
that could later be readily applied to additional multiplex
viral family reactions with viral DNA and/or RNA. Each
25ml reaction contained 1 SSIII buﬀer, 1U of SSIII RT/
Taq enzyme, 4.8mM MgSO4, 0.1mM each primer, and a
viral template mass of 2.7pg ( 10
4 copies). Tests were
performed in triplicate and corresponding negative
controls were run under identical conditions except that
viral template was replaced with nuclease-free water
(Ambion, Austin, TX, USA). All reactions were thermo-
cycled on the Bio-Rad DNA Engine (Hercules, CA, USA)
as follows: one cycle of 2min at 94 C; 40 cycles of 15s at
94 C, 30s at 43.9 C, 1min at 68 C; one cycle of 5min at
68 C. In line with our goal to create a protocol applicable
to both DNA and/or RNA templates, we veriﬁed that
inclusion of an RT step (one cycle of 30min at 45 C)
does not alter the outcome of the subsequent PCR when
working with DNA template (data not shown). As such,
for all Poxviridae 16-plex results reported here, an RT step
was not used. Another goal was to establish reaction
conditions that can be applied to any multiplex viral
primer set without the need for re-optimization, assuming
the primer set is designed with the same general parameter
contraints (Tms, etc.) used to compute the 16-plex pre-
sented here. As such, we ﬁrst optimized master mix
conditions, where it was determined that a 4.8mM
MgSO4 concentration resulted in most optimal ampliﬁca-
tion. Similarly, we determined the optimal annealing tem-
perature based on results from annealing temperature
gradient experiments. A more detailed discussion on the
optimization of reaction conditions for ampliﬁcation
with our short primer viral multiplexes is the subject
of a separate paper in preparation (Hiddessen and
co-workers).
This multiplex was compared against the human
genome, predicting 233 amplicons between 50 and
1000bp from the Poxviridae 16-plex. For empirical tests
against background human nucleic acids, we followed
the same reaction conditions as above. In these tests,
vaccinia DNA was held at a constant concentration
of 2.7pg (1.3 10
4copies), and serial dilutions of
human genomic DNA (Novagen, Madison, WI, USA),
were added to the vaccinia PCR reaction mix, starting
at 2.7pg and titrating down over 4 orders of magnitude
to 2.7 10
–4pg. These experiments were performed using
mass ratios of vaccinia:human DNA at 1:1, 10:1, 100:1,
1000:1 and 10000:1. These correspond to copy number
ratios of vaccinia:human genomes of 1.3 10
4:0.82,
1.3 10
4:0.082, 1.3 10
4:0.0082, 1.3 10
4:0.00082 and
1.3 10
4:0.000082, respectively.
All PCR experiments were analyzed on 3% agarose
TBE gels containing ethidum bromide that were
purchased from Bio-Rad (Hercules, CA, USA). Blue
juice
TM 10  loading dye was purchased from Invitrogen
(Carlsbad, CA, USA) and diluted to 2  before use.
A 50-bp DNA ladder was purchased from Novagen
(Madison, WI, USA). For analysis, 15ml from each
separate 25ml PCR reaction were combined with 2mlo f
of loading dye and 15ml of the loading-dye/product
mixture was loaded per well and electrophoresed for 1h
40min at 85V.
For conﬁrmation of amplicon sequence, 9mlo f
ampliﬁed PCR product was mixed with 4ml of ExoSap-it
(USB, Cleveland, OH, USA) and incubated at 37 C for
15min followed by a denaturation step at 80 C for 15min.
Sanger sequencing was then performed with the
BigDye V3.1 Terminator Kit (Applied Biosystems, Inc.,
Foster City, CA, USA). Single reactions contained
4ml of Ready Reaction Mix, 0.2-mM primer, 2ml5  
Sequencing Buﬀer, 11.5ml of nuclease free water
(Applied Biosystems, Inc.) and 2ml of post-Exosap-it
PCR product. The sequencing reaction used the follow-
ing thermocycling proﬁle: 1 cycle of 94 C for 1min;
25 cycles of 94 C for 15s, 38 C for 30s and 60 C for
4min. Two microliters of sequencing reaction product
was combined with 18ml of Hi-Di
Tm Formamide
(Applied Biosystems, Inc.) and run on the ABI 3130
(Applied Biosystems, Inc.). The results were analyzed
using Sequencing Analysis v5.2 (Applied Biosystems,
Inc.).
RESULTS
Universal viral primers
Predicting a set of universal viral primers that are all
mixed in a single large reaction, we predict that 1008
primers of length 10nt would be required to ensure ampli-
ﬁcation of at least one fragment of length 80–620bp from
every viral genome. These are predicted to generate a
mean and maximum number of amplicons per viral
genome of 13.2 and 948, respectively. Binning the
primers into smaller sets of 20 primers/bin doubled the
number of primers required, as Figure 1 shows the
fraction of viral genomes ampliﬁed versus the number of
primers, for primers ranging from 6 to 18nt in length.
About 2000 binned 10-mers are required to amplify
100% of sequenced viruses, generating a mean of 1 and
maximum of 2.9 amplicons per genome, on average. Using
traditional-length 18-mer primers nearly doubles the
number to  3700 primers. The incomplete curve for
7-mers was from inappropriate settings for this oligo
length, since some genomes do not contain pairs of
7-mers with the required Tm, as given in the Supple-
mentary Tables S1 and S2, within the desired amplicon
length range. The concave curves showing diminishing
returns reﬂect biased sequence availability rather than
any particularly highly conserved primers: the primers
that amplify the largest number of sequences are all
from inﬂuenza, as far more sequences are available for
this species than for any other.
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primer sets
The increase in sequence data requires  700 more 10-mer
primers to amplify all sequenced viruses in 2007 compared
to 2004 (Figure 2). While the increase in the number of
sequences used between the two dates was only  15%, the
number of primers required increased by 48%, illustrating
the substantial increase in diversity represented by the
additional sequence data. Figure 2 also shows that
removing all Tm constraints allows fewer primers to be
used since no conserved primers are eliminated due to
Tm, as some AT rich subsequences tend to be fairly
conserved. Figure 3 shows that a universal primer set
predicted using the 2004 sequence data would amplify
only 35% of the 2007 sequences using primers of at least
10nt in length. Shorter primers increase this fraction to
over 60%, due to the higher likelihood of occurrence and
conservation of shorter oligos, but even so, a multiplex of
7-mers is not guaranteed to amplify a fragment from every
virus. The minor diﬀerences in the number of genomes
detected between 12, 13, 14 and 15-mers can be attributed
to the facts that a greedy but not necessarily optimal
algorithm is used to select one solution from among
many, that the primers in a particular set depend on
the Tm ranges we used as well as length diﬀerences, and
the unpredictable nature of novel viral sequences
accumulated between 2004 and 2007, rather than any
real diﬀerence in the ability to detect genomes among
those primer sets.
Predicting eﬀects of contamination from human DNA
If all human DNA cannot be removed from the sample,
simulations indicate that on average, multiplexes of
10-mer primers are expected to produce hundreds of
amplicons from the human genome, which would appear
as a smear on a gel (Figure 4). With primers of length
11–14, there is a large variation among bins. While most
short sequences do occur in the human genome (33), an
amplicon requires that two occur in proximity, and
primers  11 bases make this a sporadic event for bins
with only 10 primers. Nonetheless, imperfect sample puri-
ﬁcation to eliminate eukaryotic nucleic acids could be
problematic for universal viral priming using primers
shorter than 15 bases, particularly for multiplexes of
10 or more primers.
Family identiﬁcation by sequencing products from universal
10-mer primer set versus randomly ampliﬁed fragments
If universal viral primers ampliﬁed fragments from a
newly emerged virus, would the product sequences show
similarity to others in the same family? We predicted
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(Australian bat lyssavirus, Crimean Congo hemorrhagic
fever, Nipah, Hendra, Venezuelan equine encephalitis,
West Nile, Ebola, Hanta, hepatitis C and Marburg
viruses) using the universal 10-mer primer set and
BLASTed (blastn) (34) those amplicon sequences against
either other species in the same target family or viruses in
other families. On average, 87% of the amplicons had
BLAST hits in the correct family, with an average of
135 hits per amplicon. In contrast, only 11% of amplicons
had hits in other, nontarget families, with an average of
2.5 hits per amplicon. For comparison, 72% of randomly
selected fragments of 200bp (or 65% and 78% for 100-bp
and 600-bp fragments, respectively) had hits in the correct
family with an average of 59 hits per amplicon, and 2.8%
had hits in other families with an average of 2.4 hits per
amplicon. Thus, universal primers do amplify more
conserved regions than randomly selected fragments.
These rough calculations depend heavily on available
sequence data, and are likely to signiﬁcantly overestimate
our ability to characterize a truly novel virus, extra-
polating from results of viral metagenomic sequencing in
which over 60% of the sequences cannot be identiﬁed
based on BLAST comparisons to existing sequence
databases (2).
Viral family primers
The number of family-level primers for each family, and
the number of genomes available for generating those
primer sets, is given in Table 1, for three alternative
settings: short primers of 10–15nt with Tm 40–45 C,
standard length primers of 17–21nt and Tm 55–60 C,
and the same but requiring that each primer subsequence
of at least 17nt be unique to the target viral family relative
to other viral families. At least one amplicon of
200–800bp was required from every genome. Hypothe-
tically, the worst-case scenario to amplify a target set of
N sequences would require 2N primers. MPP requires on
average only 37% or 45% of this number, for primers of
length 10–15nt or 17–21nt without the requirement for
family speciﬁc primers, respectively (averaged across
families, omitting those families for which the com-
putations were not run to completion). The most diverse
families, in particular Bunyaviridae, Geminiviridae,
Polydnaviridae, Reoviridae, Retroviridae, Siphoviridae
and Orthomyxoviridae require so many primers that
actually applying family-level ampliﬁcation is probably
infeasible. For these, more restricted target sets may be
necessary, such as limiting to a single segment for the
segmented families or to subclades, and possibly the
incorporation of primers with degenerate or inosine
bases. Some families with many genomes can be ampliﬁed
with relatively few primers, such as Coronaviridae,
Hepadnaviridae, Poxviridae, Togaviridae, Microviridae
and Polyomaviridae. Using primers of length 10–15-mers
or 17–21-mers, 66% or 63%, respectively, of the viral
families have primer sets of 40 or fewer primers
(20 primer pairs), which is feasible for typical multiplexes.
The sizes of the family-level primer sets show a trend
for an increase with the number of available sequences
in the family (Figure 5, P=0.14). There is no clear
relationship between the number of primers in the set
and whether the genomes are single or double stranded
RNA or DNA. All family primer sequences are available
as Supplementary Data.
Species-level primers for divergent RNA viruses
Primer design with the MPP software indicates that rela-
tively few primers are required to amplify all sequenced
genomes of HIV-1, FMDV and Norwalk virus (Table 2),
and these can be calculated in minutes. Inﬂuenza A HA
and NA segments demand large numbers of 10-mer or
17–18-mer primers and hours to calculate, so one could
break these into subgroups, possibly by serotype, as
shown for several HA serotypes in Table 3. The percent-
age of genomes ampliﬁed versus the number of primers
used, for primers of either 10-mers or 17–18-mers, is
shown in Figure 6. This plot shows that a large fraction
of targets are ampliﬁed with only 2 primers, and the
addition of subsequent primers shows diminishing
returns in amplifying fewer, more divergent targets not
detected by the initial, more conserved, primer pair,
although the true diminishing returns depend on the
extent to which available sequence data is an unbiased
representation of diversity.
The more traditional method of attempting to ﬁnd
primers from a MSA would be problematic, probably
requiring manually designed primer multiplexes or
highly degenerate primers. For HIV-1, for example,
there is not a single position with 100% conservation
across all sequenced isolates. Dropping the required con-
servation down to 95% (58 of the 1175 genomes could
disagree with a consensus base at any position), there
are three conserved regions of at least 18 bases, with
positions relative to the consensus: ACAGGAGCAGAT
GATACAGTA starting at position 3665; TATGGAAAA
CAGATGGCAGG starting at 7347; and CTATGGCAG
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Figure 4. Average number of bands predicted from PCR against the
human genome using the universal viral primers for the runs as
described in Figure 2, average±SD of the top 10 bins for each
primer length. For bin size of 10, we divided the universal primer
bins of 20 primers/bin into two bins each.
6296 Nucleic Acids Research, 2009,Vol.37, No. 19Table 1. Primer counts for viral family primer sets, as described in the methods
Family Number of
Target
sequences
Number
10-15-mer
primers
Targets
Ampliﬁed
(%)
Number of
17–21-mer
primers
Targets
ampliﬁed
(%)
Family Speciﬁc
Number of
17–21-mer
primers
Targets
Ampliﬁed
(%)
Adenoviridae 78 24 100.00 36 100.00 42 100.00
Alloherpesviridae 6 4 100.00 8 100.00 8 100.00
Ampullaviridae 1 2 100.00 2 100.00 2 100.00
Arenaviridae 154 90 100.00 142 100.00 146 99.35
Arteriviridae 129 10 100.00 12 100.00 12 100.00
Ascoviridae 4 4 100.00 6 100.00 6 100.00
Asfarviridae 10 2 100.00 2 100.00 2 100.00
Astroviridae 26 12 100.00 16 100.00 16 100.00
Baculoviridae 52 20 100.00 44 100.00 48 100.00
Barnaviridae 1 2 100.00 2 100.00 2 100.00
Bicaudaviridae 2 2 100.00 4 100.00 4 100.00
Birnaviridae 219 22 100.00 26 100.00 30 100.00
Bornaviridae 13 4 100.00 4 100.00 4 100.00
Bromoviridae 321 124 100.00 165 100.00 139 93.46
Bunyaviridae 1265 345 93.04 183 75.81 129 62.13
Caliciviridae 210 48 100.00 80 100.00 82 100.00
Caulimoviridae 66 56 100.00 58 100.00 60 100.00
Chrysoviridae 16 18 100.00 24 100.00 24 100.00
Circoviridae 594 20 100.00 34 100.00 34 100.00
Closteroviridae 61 53 100.00 64 100.00 64 100.00
Comoviridae 80 68 100.00 78 100.00 90 100.00
Coronaviridae 279 24 100.00 30 100.00 34 100.00
Corticoviridae 1 2 100.00 2 100.00 2 100.00
Cystoviridae 21 19 100.00 24 100.00 24 100.00
Dicistroviridae 25 22 100.00 24 100.00 26 100.00
Endornaviridae 6 8 100.00 8 100.00 8 100.00
Filoviridae 39 8 100.00 7 100.00 12 100.00
Flaviviridae 2866 102 100.00 142 99.97 158 99.97
Flexiviridae 195 121 100.00 170 100.00 164 92.31
Fuselloviridae 6 2 100.00 4 100.00 4 100.00
Geminiviridae 1429 162 100.00 172 94.47 204 91.11
Globuloviridae 2 2 100.00 4 100.00 4 100.00
Hepadnaviridae 2141 16 100.00 17 100.00 22 99.91
Hepeviridae 134 8 100.00 18 100.00 21 100.00
Herpesviridae 98 27 100.00 48 100.00 54 100.00
Hypoviridae 7 4 100.00 8 100.00 8 100.00
Inoviridae 33 30 100.00 32 100.00 34 100.00
Iridoviridae 13 8 100.00 14 100.00 14 100.00
Leviviridae 12 12 100.00 14 100.00 14 100.00
Lipothrixviridae 8 8 100.00 8 100.00 8 100.00
Luteoviridae 99 22 100.00 26 100.00 28 100.00
Malacoherpesvirid 1 2 100.00 2 100.00 2 100.00
Marnaviridae 1 2 100.00 2 100.00 2 100.00
Metaviridae 4 4 100.00 4 100.00 4 75.00
Microviridae 105 10 100.00 14 100.00 16 100.00
Mimiviridae 1 2 100.00 2 100.00 2 100.00
Myoviridae 95 90 100.00 112 100.00 116 100.00
Nanoviridae 206 70 100.00 88 99.51 78 91.26
Narnaviridae 9 14 100.00 18 100.00 18 100.00
Nimaviridae 3 2 100.00 2 100.00 2 100.00
Nodaviridae 41 22 100.00 26 100.00 26 100.00
Ophioviridae 15 22 100.00 26 100.00 28 100.00
Orthomyxoviridae 32988 318 99.76 35 74.41 78 82.15
Papillomaviridae 272 115 100.00 167 94.85 216 99.63
Paramyxoviridae 252 56 99.21 80 99.21 83 99.21
Partitiviridae 74 72 89.19 88 98.65 90 97.30
Parvoviridae 136 48 100.00 62 100.00 62 100.00
Phycodnaviridae 10 6 100.00 8 100.00 12 100.00
Picobirnaviridae 2 4 100.00 4 100.00 4 100.00
Picornaviridae 842 103 100.00 119 100.00 126 100.00
Plasmaviridae 1 2 100.00 2 100.00 2 100.00
Podoviridae 90 75 100.00 92 100.00 96 96.67
Polydnaviridae 232 331 99.57 307 80.17 266 68.10
Polyomaviridae 669 28 100.00 34 100.00 38 100.00
Potyviridae 452 110 100.00 178 100.00 196 100.00
(continued)
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far apart to be used as primers for most polymerases used
in diagnostic PCR protocols, where amplicons must
typically be less than 300 bases long for eﬃcient ampliﬁ-
cation. A recently published study (35) selected primers
from the 50 LTR U5 end to the Gag-Pol start (50-TAGC
AGTGGCGCCCGA-30 and 50-TCTCTCTCCTTCTAGC
CTCCGC-30), but a comparison against available genomic
data indicates that 487 of the 1175 genomes (41%) do not
contain a sequence match for this primer pair, so may fail
to be ampliﬁed.
For inﬂuenza A segment HA, the size of the longest
conserved region from the 95% consensus is only 5
bases, and for segment NA, only 6 bases, insuﬃcient for
even a single primer. For FMDV and Norwalk virus, the
longest 100% conserved regions are 9 and 6 bases, respec-
tively. The MPP software makes it straightforward for
a nonexpert to predict a multiplex-compatible set of
primers to amplify all targets, even for enormous and het-
erogeneous target sets that cannot be aligned.
Comparison with other software
For comparison, we considered other software options for
designing primers for these heterogeneous viruses.
FastPCR (www.biocenter.helsinki.ﬁ/bi/programs/fastpcr
.htm) and GeneUp (25) were the only programs that did
not require an MSA as input. The FastPCR algorithm for
group-speciﬁc PCR (i.e. universal ampliﬁcation) designs
PCR primer pairs individually for each target sequence
without regard for primer conservation among targets,
and then compares each primer pair to the other targets.
This is a brute force strategy that is only suitable for small
target sets and short target sequences (appropriate for
gene lengths, but not for viral genome-length sequences).
We ran the FastPCR software on our internal servers, but
it did not complete ‘group-speciﬁc PCR’ for the smallest
data set, Norwalk virus, after running for 18h, and for
‘multiplex PCR’ gave the error message ‘No compatible
combination of pair primers for multiplex PCR found’.
GeneUp simulates PCR with pairwise combinations of
candidate primers which pass length, Tm, GC%, and pal-
indrome ﬁlters against all target sequences, and uses a
greedy algorithm to build a primer set to amplify all of
the targets. Since testing all possible pairwise oligo-
nucleotide combinations against each target explodes in
time and memory for large target sets, a cap on the
maximum number of candidate primers to be tested
must be imposed, presumably using the most common
oligos, although this is not explicit in the paper. Then a
Table 1. Continued
Family Number of
Target
sequences
Number
10-15-mer
primers
Targets
Ampliﬁed
(%)
Number of
17–21-mer
primers
Targets
ampliﬁed
(%)
Family Speciﬁc
Number of
17–21-mer
primers
Targets
Ampliﬁed
(%)
Poxviridae 148 10 100.00 20 100.00 22 100.00
Reoviridae 3127 169 52.13 195 58.68 155 46.56
Retroviridae 1652 118 99.94 193 100.00 227 100.00
Rhabdoviridae 104 58 100.00 68 100.00 76 100.00
Roniviridae 2 2 100.00 2 100.00 2 100.00
Rudiviridae 5 6 100.00 6 100.00 6 100.00
Sequiviridae 9 6 100.00 10 100.00 10 100.00
Siphoviridae 236 156 100.00 214 99.58 220 0.00
Tectiviridae 10 4 100.00 4 100.00 6 100.00
Tetraviridae 6 8 100.00 12 100.00 12 100.00
Togaviridae 140 23 100.00 38 100.00 46 99.29
Tombusviridae 81 55 100.00 68 100.00 70 100.00
Totiviridae 38 48 100.00 54 97.37 58 100.00
Tymoviridae 24 13 100.00 29 100.00 34 100.00
Grey shaded entries indicate where calculations were not run to completion. In other cases (not shaded) where fewer than 100% of targets were
predicted to be ampliﬁed, the algorithm failed to ﬁnd primer pairs that met all the required speciﬁcations for the remaining targets, that is, primers
in the right length, Tm, and amplicon length range, with hairpin and dimer avoidance with other primers already selected to be in the set, could
not be found.
For 10–15-mers, Tm=40–45 C and for 17–21-mers, Tm=55–60 C.
For both, the amplicon length range was 200–800bp.
None of the calculations that completed required more than the 16GB of RAM that was available.
Figure 5. Number of primers required to amplify fragments from each
complete genome or segment in the family versus the number of avail-
able sequences in that family. Primer parameters were length 17–21-
mers, Tm between 55 C and 60 C.
6298 Nucleic Acids Research, 2009,Vol.37, No. 19PCR simulation (performing a text search for the primer
in the target sequence) of each pair versus each target is
performed. Unfortunately, the most common oligos may
not occur in the correct orientation or distance to serve as
primer pairs, so that multiple iterations of the entire
process must be performed before a set covering all
targets is obtained. MPP, in contrast, uses an eﬃcient
ranking algorithm to favor pairs of primer candidates
that will produce amplicons of the right size in the most
targets. Because of the MPP hashing algorithm and data
structures, those targets that are ampliﬁed is easily deter-
mined without simulating PCR. A copy of the GeneUp
software for testing could not be obtained from the
authors.
The PDA-MS/UniQ approach (26) uses a hash index of
4-mers and scoring heuristic to identify common regions
in the target sequences with the most shared tetramers.
Simulating combinations of candidate primers selected
from these common regions is then performed using a
genetic algorithm. Their genetic algorithm is a more
scalable approach than those above, and the quality of
the solution may be improved with more compute
power, although a potential disadvantage of genetic
algorithms is that they can be slow, particularly if there
are very many possible combinations. For computational
tractability, they limited primer size to 12nt, and avoid-
ance of hairpins and primer dimers was not modeled. This
software was not available for download or on a public
web server.
Figure 6. The percentage of genomes ampliﬁed versus the number of
primers used, for primers of either 10-mers or 17-18-mers, for several
highly diverse virus species, (A) HIV-1, FMDV and Norwalk; and
(B) Inﬂuenza A HA and NA segments. The two most highly conserved
primers amplify a large fraction of genomes, and additional primers show
diminishing returns in detecting the remaining, more divergent sequences.
Table 2. Summary of results of primer set prediction for several diverse RNA virus species for primers of length 10 or 17–18nt, the longest stretch of
bases conserved among the targets in a multiple sequence alignment, illustrating the diﬃculty of selecting conserved primers, and the time required to
perform the primer set selections
Virus species Number of
sequences
Number of
10-mers
Number of
17–18-mer
primers in set
Longest
conserved region
from MSA (nt)
Processing time on
1cpu of an AMD
Opteron to calculate
10-mer primers (hours)
Processing time on
1cpu of an AMD
Opteron to calculate
17–18-mer primers (hours)
NA segment of
Inﬂuenza A*
6375 52 120 5 5.7 28.9
HA segment of
Inﬂuenza A*
5440 73 153 1 6 29.5
HIV-1 1175 6 16 0 1.6 9.1
FMDV 187 4 6 9 0.18 0.7
Norwalk 41 7 20 6 0.1 0.5
*For Inﬂuenza A HA and NA segments, all complete sequences, including lab strains, from all hosts, countries and serotypes were downloaded from
the NCBI Inﬂuenza Virus Resource database (http://www.ncbi.nlm.nih.gov/genomes/FLU/Database/multiple.cgi) on 18 January 2008.
Primer sequences are provided as Supplementary Data.
Table 3. Summary of the number of 17–18-mer primers predicted to
amplify several inﬂuenza A HA serotypes
Inﬂuenza A
HA Serotype
Number of
sequences
Number of 17–18-mer
primers in set
H1 1080 24
H2 108 8
H3 1972 15
H5 1325 16
H7 256 8
Primer sequences are provided as Supplementary Data.
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these tools could not be tested on larger (e.g. family level)
primer prediction problems where alignments would not
be possible or appropriate, we nevertheless attempted to
run these tools on the alignable species-level target sets.
The Primaclade (24) webserver timed out for the smallest
alignments we tested, Norwalk and FMDV. CODEHOP
(23) requires protein alignment as input so is not appro-
priate for whole-genome (nucleotide) alignments.
GreeneSCPrimer (20) did generate a number of degen-
erate primer candidates from the MSAs for Norwalk and
FMDV, requiring the user to manually select a combi-
nation of forward and reverse groups from a set of
options. We ran GreeneSCPrimer using length, Tm, etc.
settings mirroring or more lenient than those we used
for Table 3 (Tm=55–65 C, GC%=20–80%, length
17–25bp, 100% coverage, product size 80–620bp,
allowed Tm diﬀerence 10 C, others left as defaults).
HYDEN (22) also generated degenerate candidates from
a MSA, although it does not check Tm and the length is
limited to a single value rather than a range. For our tests
using HYDEN, we used a length of 18 rather than 17
because of the lack of Tm control, and allowed 0
mismatches. The GreeneSCPrimer option requiring the
fewest total primers for the Norwalk set required 18
primers, four of which had either 2-fold or 4-fold degen-
eracy so the actual number of priming sequences would be
26, compared to a total of 20 non-degenerate primers
predicted by MPP (Supplementary Data). HYDEN
generated four degenerate primers covering only 34 of
41 sequences, each with 3- or 4-fold degeneracy for
Norwalk, which translates to 15 priming sequences in
the reaction. One would need to ﬁnd primers to amplify
the remaining seven sequences. Small degenerate priming
sets (e.g. four primers in this case) are less expensive to
purchase, but because of dilution eﬀects from the many
sequence combinations actually present (15 priming
sequences in the PCR), sensitivity may be reduced
compared to nondegenerate priming. However, using a
smaller set of degenerate signatures such as those from
HYDEN may be preferable, and is a capability that
could improve MPP in a future version.
For FMDV, MPP predicted six nondegenerate
multiplex compatible primers to amplify all targets.
GreeneSCPrimer generated a number of candidates, and
manual inspection identiﬁed that the best of those primer
combinations would require 6 primers, one of which had
2-fold and another had 3-fold degeneracy, totaling 9
actual priming sequences in a reaction (Supplementary
Data). This compares with two primers each with 4-fold
degeneracy using HYDEN (eight priming sequences in a
reaction), to amplify 98% (183 of 187) targets. Again, the
small number of signatures predicted by HYDEN is desir-
able for some applications, although the degeneracy is
high and these must be supplemented to pick up the few
outlying sequences
The aim of the MuPlex software (28,29) is to parti-
tion primer pairs into multiplex-compatible bins for SNP
genotyping, and it does not employ any algorithm during
primer selection to minimize the number of primers to
amplify all targets, yielding a one-to-one correspondence
between number of primer pairs versus number of targets.
However, the MuPlex graph-based algorithm to partition
primers into bins is more sophisticated than the simple
binning scheme of MPP. In future work, MPP could be
used to identify a universal set of primers and the backend
of MuPlex used to optimize how they are binned into
separate reactions.
In summary, no software except MPP was capable of
predicting primer sets for the larger target sets we
examined or generating a multiplexed primer set without
a MSA for any of the target sets we examined, even the
smallest ones containing only a single species. Only
HYDEN and GreeneSCPrimer, both requiring MSA
inputs, completed for the two smallest target sets, selecting
smaller sets of degenerate primers than the nondegenerate
MPP primers. If target sets are suﬃciently conserved so
that a reasonable MSA can be built, and degenerate
primers are acceptable, these tools may be preferable
over MPP. However, for larger and more diverse target
sets, only MPP completed.
Poxviridae experimental results
Using the experimental conditions described in the
‘Methods’ section, we tested the Poxviridae 16-plex
(Table 4) against vaccinia virus, Lister strain DNA. As
assessed by agarose gel analysis, we achieved speciﬁc
ampliﬁcation of the predicted 617-bp amplicon for the
target vaccinia genome (lane 3, Figure 7). The band does
not appear in the no template control shown in lane 4
(Figure 7).
To conﬁrm that the amplicon observed in gel analysis
was a speciﬁcally ampliﬁed product from vaccinia
virus, Lister strain, we sequenced the product according
to the procedures described above. An analysis of
the high-quality sequence read data taken from the
electropherogram yielded a 95% identity (maximum) to
vaccinia virus, Lister strain (AY678276.1) with a query
Table 4. Sequence and size (nt) information for the 16 primers in the
predicted family-level multiplex for Poxviridae viruses used in these
experiments
Primer sequence Primer size (nt)
CGGAGACCAA (FP 617) 10
TCGTCGTCCA (RP 617) 10
TGTTGGTGTG 10
TCGTCTACGA 10
TGTGGTCCTT 10
CCATGTTCGC 10
TCGAGGAGAA 10
CCGGCTCCAG 10
TGAACCTGGT 10
GCGCACGTAC 10
TCACGCATCT 10
GGGAAACAGC 10
ACCGTTGTCA 10
TACCATCGTC 10
AACCTGTGCA 10
GGCGGAGGTA 10
The forwardandreverseprimers(FP,RP)inbold arepredictedtoamplify
vaccinia Lister with the indicated product length (617-bp amplicon size).
6300 Nucleic Acids Research, 2009,Vol.37, No. 19coverage of 99% and an e-score of 0 (no data shown).
These values indicate that the sequenced product was
vaccinia DNA and not ampliﬁcation from an exogenous
nucleic acid source, e.g. host cell.
Notably, our multiplex reaction did not produce a
smear (lane 3, Figure 7) that would be indicative of
nonspeciﬁc priming of either the target or exogenous
host cellular nucleic acids. While the exact manufacturer’s
extraction protocol is proprietary, it is generally known
that a standard sucrose gradient ultracentrifugation step
is used to enrich for the viral capsids prior to viral nucleic
acid extraction. However, to the best of our knowledge, no
nuclease digestions are performed prior to viral capsid
lysis. Furthermore, while the viral ‘extract’ contains a
mixture of both viral DNA and cellular nucleic acids,
the exact proportions of host cell and viral nucleic acids
cannot be determined. Thus, our results indicate that a
multiplex of 16 primers of 10nt each ampliﬁes only the
speciﬁc predicted band from vaccinia.
In some applications, such as clinical or biodetection
applications, the exogenous nucleic acids from other
eukaryotic sources, notably human sources, may be
present in varying and unknown concentrations. To test
the eﬀects of background human genomic DNA on the
performance (ampliﬁcation speciﬁcity) of the Poxviridae
16-plex primer set, we conducted PCR reactions across
a series of mass ratios of vaccinia Lister DNA:human
genomic DNA at 1:1, 10:1, 100:1, 1000:1 and
10000:1. These correspond to approximate copy number
ratios of vaccinia:human genomes of 1.3 10
4:0.82,
1.3 10
4:0.082, 1.3 10
4:0.0082, 1.3 10
4:0.00082 and
1.3 10
4:0.000082, using genome sizes of 1.9 10
5bp
and 3 10
9bp for vaccinia and human DNA, respectively.
For context, there are 6.58pg or two copies of the genome
in one human cell. Our algorithm predicted 233 amplicons
between 50 and 1000bp from the human genome. In
experiments, this would appear as a ‘smear’ on the
agarose gel, which indeed was observed for the mass
ratios of 1:1 and 10:1 (Figure 7, lanes 6 and 7, respec-
tively). However, even at a ratio of 10:1 vaccinia:human
DNA (lane 7), the 617-bp vaccinia amplicon is clearly
visible on the gel, despite the numerous nonspeciﬁc
amplicons. At ratios of 100:1, 1000:1 and 10000:1
(lanes 8, 9 and 10, respectively, Figure 7), the smear is
drastically reduced to nonexistent (at the resolution of
the agarose gel), and the vaccinia amplicon is readily
visible. For comparison, we tested the 16-plex primers
against the same mass of human DNA in the absence of
vaccinia DNA at 2.7pg (the 1:1 ratio mass), 0.027pg
(100:1 mass) and 2.7 10
 4pg (10000:1 mass) (lanes
12, 13, and 14, respectively, Figure 7). The data show a
similar smear at 2.7pg as was observed when vaccinia
DNA was present (lane 6). However, the low-intensity
617-bp amplicon from vaccinia is visible in lane 6 (with
vaccinia) while a similar amplicon is not present in lane 12
(without vaccina). These results provide evidence that
ampliﬁcation with these family level primer sets will
depend on viral titers in the actual sample, and that
there are cases where ampliﬁcation will either not be
possible or require additional sample puriﬁcation steps.
However, as discussed further in the next section,
speciﬁc ampliﬁcation with a short-primer multiplex
could be used for selective enrichment of viral targets by
generating amplicons with known sequence, which may
be feasible for viral detection if combined with a probe-
based amplicon detection method such as TaqMan or
Luminex bead based suspension arrays (http://www
.luminexcorp.com/).
We compared recently published conserved
Orthopoxvirus primers (36) to the 148 Poxviridae
genomes, and computational predictions suggest that 67
of the available genomes might not be ampliﬁed by
the two primers they designed for the Orthopox genus.
These included a number of monkeypox, ectromelia,
several vaccinia and a couple of variola strains.
However, in permissive hybridization conditions it is
possible that primers would anneal despite mis-
matches to target, allowing more of the targets to be
ampliﬁed. Four conserved Orthopoxvirus primers from
an earlier publication (37), before many of the
Poxviridae genomes were available, do not match 53
genomes, including a number of monkeypox, ectromelia,
camelpox and one variola minor genome. The primers
in (37) included inosine bases, which we replaced with
each possible A, T, G and C base in all possible
combinations for our primer-target comparison. Thus,
published Orthopoxvirus primers may fail to amplify
many desired targets.
DISCUSSION AND CONCLUSIONS
Primer design for ampliﬁcation and detection of divergent
target sequences can be challenging, and this problem
will only grow as sequencing technologies improve.
Figure 7. PCR ampliﬁcation of vaccinia DNA, Lister strain with the
16-plex Poxviridae primer set, with (lanes 6–10) or without (lanes 3 and
4) human DNA present in the reaction, for a reaction containing
4.8mM MgSO4, 0.1mM each primer and 2.7pg ( 10
4 copies) of
vaccinia Lister DNA, and using an annealing temperature of 43.9 C.
Lane 3 shows speciﬁc ampliﬁcation of vaccinia Lister DNA followed by
the no template control in lane 4. Lanes 6–10 represent the experiments
with mass ratios of vaccinia:human DNA of 1:1, 10:1, 100:1, 1000:1
and 10000:1, respectively. Lanes 12–14 represent ampliﬁcation of
human DNA only (no vaccinia present in reaction) for the same
masses used at the 1:1, 100:1 and 10000:1 ratios (or 2.7pg,
0.027pg and 2.7 10
–4pg human DNA, respectively). Lanes 5, 11
and 15 did not contain any sample. The arrow on the left points to
the expected band (617bp). The arrows on the right correspond to the
50-bp DNA ladder (lanes 1 and 16 contain the same ladder).
Nucleic Acids Research, 2009,Vol.37, No. 19 6301Some methods are limited in scalability, particularly those
requiring a MSA as input. Developing a PCR multiplex is
often a tedious mix-and-match process from among
primers originally designed to work in singleplex. We
describe the MPP algorithm based on hashing of
conserved k-mer subsequences that requires no MSA
and where multiplex-compatible primer sets are built
de novo to avoid primer dimer and hairpin formation to
the extent that can be predicted based on free energy
calculations.
The algorithm seeks to minimize the number of primers
to amplify all targets, although because the algorithm is
heuristic and not an exhaustive search of all combinations
of primers, the smallest primer sets may not always be
selected. This is an NP complete problem (38), so an
exhaustive search for the global optimum is only practical
for very small target sets. It is also beyond the scope of the
current software to predict priming with mismatches
between target and primer, which may occur under non-
stringent hybridization conditions or for mismatches at
the 50 end of a primer. While allowing for such priming
would reduce the number of primers needed to amplify all
targets, it would substantially slow the algorithm and
increase memory requirements. Nor do we claim to have
taken all steps to optimize (e.g. through parallelization,
see Supplementary Methods) for speed or memory, but
instead present this software as a simple embodiment of
one alternative to MSA for multiplex primer design.
The software handles a large number of input
sequences, although for very diverse targets the predicted
primer multiplex may be too large to be empirically
feasible. For many target sets, such as those including
all the genomes of a species, predicting a universal
primer set requires only minutes up to a few hours,
although for inputs with thousands of sequences a run
may take days. We used MPP to design a universal
primer set for a target set of all virus genomes, and
showed that even if short primers are used, thousands of
priming sequences would be required to amplify all
sequenced viruses. We then applied MPP to design
multiplex family level primers for every viral family, as
well as for some diverse species target sets too large for
other available primer prediction software.
In addition to ﬁnding primers for viral detection,
another application of MPP could be to design multiplex
primers for homologs in a gene family. The user can
specify an appropriate product length range to ensure
ampliﬁcation of an adequate span across the gene. MPP
could also be used to design multiplex primer sets for
unrelated target sequences, for example, multiple bacterial
and viral species or gene families, in a single reaction.
Since no sequence alignment is required, there is no need
for any sequence conservation among targets. Recent
work showed that a large-scale multiplex of 800 primer
pairs speciﬁcally designed to detect a diverse set of genes
from nine pathogens improved sensitivity on a microarray
by up to 1000-fold (39). The MPP software could be used
to design multiplex primer sets for similar work.
We demonstrated the application of the algorithm
experimentally using puriﬁed vaccinia DNA, amplifying
the expected band with a Poxviridae short primer
multiplex PCR, and conﬁrmed the band’s expected
sequence. We provided an example of the eﬀect of back-
ground nucleic acids by spiking human DNA into the
PCR reaction over a series of mass ratios. While a band
for vaccinia was visualized by slab gel electrophoresis
for all mass ratios, background DNA smears were also
clear at the higher ratios. At a mass ratio of 1:1
vaccinia:human DNA, there are 2.7pg or 0.82 copies of
the human genome present in the reaction. To place this
into context, there are  6.58pg or two copies of genomic
DNA in one human cell. Thus, the results from the 1:1
mass ratio reaction represents the impact that  41% of
the total DNA content from one human cell could have
on the results, when analyzed by slab gel electrophoresis.
In a clinical sample, there could be a much greater number
of human cells and DNA. Ampliﬁcation with these family
level primer sets will depend on viral titers in the actual
sample, and these experiments show that there are cases
where ampliﬁcation will either not be possible or require
additional sample puriﬁcation steps. While short primer
PCR multiplexes may enable ampliﬁcation of diverse
target sets, they will not match the speciﬁcity of longer
primers. Combination of these short primer multiplexes
with digitized, microﬂuidic-based picoliter reactions (40)
and/or next-generation microﬂuidic-based sample puriﬁ-
cation technologies that have the ability to isolate target
from contaminating nucleic acids may help to overcome
this limitation. However, even in the absence of such
technologies, a highly conserved short primer multiplex
could enrich ampliﬁcation products for members of a par-
ticular viral family compared to randomly ampliﬁed
or unampliﬁed sample. Then it would need to be
followed by product sequencing or array hybridization,
such as TaqMan or Luminex bead-based suspension
arrays (http://www.luminexcorp.com/), to provide more
speciﬁc information about the organism(s) present, since
electrophoretic banding patterns may contain unexpected
bands, particularly if the sample contains a signiﬁcant
amount of nonviral nucleic acids.
Previous studies have shown the utility of short primer
singleplex PCR using 9-mers or 10-mers followed by gel
electrophoresis for genetic ﬁngerprinting of eukaryotes
and bacteria (41,42). For viruses, with much smaller and
more diverse genomes, the large numbers of 9-mer or
10-mer primers required to generate at least one band
from every virus as predicted by our analyses implies
that primer size would need to be as short as 5-mers to
rely on a gel banding pattern using only one priming
sequence for ﬁngerprinting viruses (unpublished data).
However, the analyses here predict that imperfect sample
puriﬁcation to eliminate eukaryotic nucleic acids could be
problematic for universal viral priming using primers
shorter than 15 bases, particularly for multiplexes of 10
or more primers. Nanda et al. (43,44) were able to achieve
suﬃcient viral isolation from cell culture samples to
allow viral identiﬁcation using viral PCR with priming
sequences as short as pentamers, so the problem of
contaminating host nucleic acids for speciﬁc, short
primer PCR of viruses is not insurmountable. They
found speciﬁc pentamer PCR to be several logs more sen-
sitive than nonspeciﬁc ampliﬁcation, provided that they
6302 Nucleic Acids Research, 2009,Vol.37, No. 19puriﬁed encapsidated viral nucleic acids prior to PCR.
Another method that has been used for virus discovery
is VIDISCA (Virus discovery cDNA-AFLP) using restric-
tion enzyme digestion, adaptor ligation, and PCR by
priming with the adaptor sequence (45,46). This method,
like the pentamer priming used by (43,44), requires prior
separation of encapsidated viral nucleic acids, as it
generates fragments from any DNA present, viral, host
or otherwise. Multiplex PCR with primers 10–15nt in
length may be yet another alternative strategy lying
between these nonspeciﬁc methods and PCR with
standard primers of at least 18nt, as we have shown
that it can add some measure of speciﬁcity for a viral
family.
In summary, we applied the MPP software to generate
multiplex-compatible primer sets for every viral family
and several divergent viral species and experimentally
demonstrated application of one multiplex set to show
nonrandom ampliﬁcation with a set of short primers.
Code and Primer Availability
Primer sets are available as supplemental material or by
request from the authors. The MPP software is freely
available for academic and nonproﬁt use at http://mpp
.llnl.gov.
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